Open AccessErrors of antithrombotic therapy in management of pregnancy and childbirth after in vitro fertilization and transfer of two embryos
Author(s) -
N. S. Stuleva,
D. A. Doronicheva,
I. V. Khamani,
Е. А. Orudzhova
Publication year - 2020
Publication title -
akušerstvo, ginekologiâ i reprodukciâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.124
H-Index - 4
eISSN - 2500-3194
pISSN - 2313-7347
DOI - 10.17749/2313-7347/ob.gyn.rep.2020.119
Subject(s) - medicine , antithrombotic , thrombophilia , in vitro fertilisation , venous thromboembolism , pregnancy , childbirth , obstetrics , gynecology , thrombosis , surgery , biology , genetics
Thrombophilia might be the essential pathogenetic mechanism of thromboembolism associated with pregnancy. Venous thromboembolism during or after assisted reproductive technologies is predicted to emerge due to increased number of women undergoing this technique. Low molecular weight heparins was effective for preventing recurrent thromboembolism and severe obstetric complications. Women with personal or family history of thromboembolism or with history of obstetric complications should be screened for thrombophilia.